Associated with our lab is the Thermo Fisher Scientific Proteomics Facility for Disease Target Discovery, which operates as a collaborative mass spectrometry facility of the Quantitative Biosciences Institutes (QBI) and the Gladstone Institutes.
This state-of-the art facility thrives on establishing collaborations in which we can leverage initial experiments to apply for collaborative funding opportunities. Learn more on the facilities website.